Business Context and Reporting Period
This Form 8-K Current Report from Inmune Bio, Inc. (INMB) covers events occurring on June 16, 2026, specifically the Company's Annual Meeting of Stockholders. The filing details the election of directors, the ratification of independent auditors, and the approval of amendments to the Company's stock incentive plan.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only quantitative data provided relates to share counts and voting results.
Material Changes and Corporate Actions
- Stock Incentive Plan Amendment: Stockholders approved the Third Amended and Restated 2021 Stock Incentive Plan. The number of shares reserved for issuance increased from 6,500,000 to 9,158,525.
- Evergreen Provision: The plan now includes an automatic annual increase in reserved shares from 2027 through 2031. The increase will be the lesser of 10.0% of outstanding shares on the preceding December 31 or a number determined by the Board.
- Share Count: As of the record date (April 20, 2026), there were 26,585,258 shares of common stock outstanding and entitled to vote.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of specific risks or contingencies beyond the standard incorporation by reference of the Proxy Statement for plan details. The Company ratified CBIZ CPAs P.C. as its independent auditors for the fiscal year ending December 31, 2026.
Stockholder Voting Results
| Proposal | Votes For | Votes Against/Withheld | Broker Non-Votes |
|---|---|---|---|
| Proposal 1: Election of Directors (All nominees elected) |
Varied by nominee (Range: 5.9M - 7.5M) |
Varied by nominee (Range: 1.4M - 3.0M) |
8,501,317 |
| Proposal 2: Ratify Auditor (CBIZ CPAs P.C.) |
17,293,255 | 107,064 (Against) 56,675 (Abstain) |
0 |
| Proposal 3: Stock Incentive Plan | 6,085,086 | 2,775,224 (Against) 95,367 (Abstain) |
8,501,317 |
Key Facts for Investor Verification
- Verify the dilution impact of the increased share reserve (9,158,525 shares) and the new evergreen provision starting in 2027.
- Note the significant number of broker non-votes (8,501,317) on the director election and stock plan proposals, indicating shares held in street name where brokers lacked discretionary voting power.
- Review the full text of the Third Amended and Restated 2021 Stock Incentive Plan (Exhibit 10.1) for specific vesting terms and eligibility criteria.
- Confirm the Company's financial status in subsequent filings (10-Q or 10-K) as this 8-K contains no financial data.